David Melnick
Chief Medical Officer
Analyst — Consultant and Senior Clinical Advisor
Other
Earnings-call appearances
-
Spero Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-10
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-16
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q4 FY2021 Earnings Call2022-03-31
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q3 FY2021 Earnings Call2021-11-10
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q2 FY2021 Earnings Call2021-08-05
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-06
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q4 FY2020 Earnings Call2021-03-11
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q3 FY2020 Earnings Call2020-11-05
Spero Therapeutics, Inc. (SPRO)